People: Hofseth Biocare ASA (HOFBC.OL)
26 Sep 2017
Dr. Bomi Framroze has served as Chief Scientific Officer of Hofseth Biocare ASA since 2010. Dr. Framroze is a Discovery scientist with over 40 worldwide patents and publications in Life Science and Chemical software research. He has been an Associate Director of Chemical Discovery at American Cyanamid, an Executive Director at Gharda Chemicals Ltd. and was Founder/CSO of Row2Technologies Inc. Since 2004 he has been carrying out Discovery research in process technologies, biochemistry and marine ingredients.
|Total Annual Compensation, NOK||5,266,000|
|Restricted Stock Awards, NOK||--|
|Long-Term Incentive Plans, NOK||--|
|All Other, NOK||--|
|Fiscal Year Total, NOK||5,266,000|